Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Accenture
Cerilliant
US Army
Queensland Health
Argus Health
Covington
Dow
AstraZeneca

Generated: November 17, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Canakinumab

« Back to Dashboard

US Patents for Canakinumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Canakinumab ➤ Try a Free Trial Use of IL-1 .beta. binding antibodies for treating peripheral arterial disease Novartis AG (Basel, CH) ➤ Try a Free Trial
Canakinumab ➤ Try a Free Trial Trilayer coated pharmaceutical packaging SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Try a Free Trial
Canakinumab ➤ Try a Free Trial Methods of treating hemophagocytic lymphohistiocytosis with an IL-33 receptor antibody The Children's Hospital of Philadelphia (Philadelphia, PA) The Trustees of the University of Pennsylvania (Philadelphia, PA) ➤ Try a Free Trial
Canakinumab ➤ Try a Free Trial Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development TRUSTEES OF BOSTON UNIVERSITY (Boston, MA) ➤ Try a Free Trial
Canakinumab ➤ Try a Free Trial Meditopes and meditope-binding antibodies and uses thereof City of Hope (Duarte, CA) ➤ Try a Free Trial
Canakinumab ➤ Try a Free Trial Substituted pyrimidinone-phenyl-pyrimidinyl compounds CONFLUENCE LIFE SCIENCES, INC. (St. Louis, MO) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Canakinumab

Drugname Country Document Number Estimated Expiration Related US Patent
Canakinumab Australia 2013344796 2032-11-16 ➤ Try a Free Trial
Canakinumab Canada 2891556 2032-11-16 ➤ Try a Free Trial
Canakinumab European Patent Office 2919811 2032-11-16 ➤ Try a Free Trial
Canakinumab Japan 2016502526 2032-11-16 ➤ Try a Free Trial
Canakinumab World Intellectual Property Organization (WIPO) 2014078502 2032-11-16 ➤ Try a Free Trial
Canakinumab Argentina 082615 2030-08-09 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Farmers Insurance
Cantor Fitzgerald
Teva
QuintilesIMS
Chubb
Mallinckrodt
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.